India’s acute shortage of COVID-19 vaccines boosts pharma profits

India's acute shortage of COVID-19 vaccines boosts pharma profits

India’s acute shortage of COVID-19 vaccines is helping pharma giants to profiteer, while the Modi regime remains elusive about universal vaccination drive

Did you like this article? Can you help us publish more by supporting us?

From as little as Rs 100 you can support People's Review in publishing more in-depth analysis on various topics

Payment from outside India is not accepted now as we are not registered under the FCRA